Aposcience AG – the secretome company

Aposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for diseases with high medical need, as the tissues afflicted by the disease process can be functionally restored, rather than just repaired.

The company's proprietary technology is based on secretomes of white blood cells (peripheral blood mononuclear cells [PBMCs]).

Aposcience develops its products for the treatment of impaired wound healing (e.g., diabetic ulcers and deep skin burn injury) and internal diseases that are related to ischemia induced inflammation (acute and chronic myocardial infarction, stroke, spinal cord injury).

 

 

Latest News
Dec
12

Approval for clinical phase II study in DFU by Austrian health agency

[more]

Oct
10

US Patent Office issues Allowance for APOSEC Patent

[more]